Evidence map›Paper›PMID 36097520›Full record

ArticleBiosensors & bioelectronics: X2022

Rapid, label-free and low-cost diagnostic kit for COVID-19 based on liquid crystals and machine learning.

Mahboube Esmailpour, Mohammad Mohammadimasoudi, Mohammadreza G Shemirani, Ali Goudarzi, Mohammad-Hossein Heidari Beni, Hosein Shahsavarani, Hamid Aghajan, Parvaneh Mehrbod, Mostafa Salehi-Vaziri, Fatemeh Fotouhi

Abstract read
In one paragraph

Article in Biosensors & bioelectronics: X, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mahboube EsmailpourNano-bio-photonics Laboratory, Faculty of New Sciences and Technologies, University of Tehran, Tehran, Iran.
Mohammad MohammadimasoudiNano-bio-photonics Laboratory, Faculty of New Sciences and Technologies, University of Tehran, Tehran, Iran.
Mohammadreza G ShemiraniNano-bio-photonics Laboratory, Faculty of New Sciences and Technologies, University of Tehran, Tehran, Iran.
Ali GoudarziNano-bio-photonics Laboratory, Faculty of New Sciences and Technologies, University of Tehran, Tehran, Iran.
Mohammad-Hossein Heidari BeniDepartment of Electrical Engineering, Sharif University of Technology, Tehran, Iran.
Hosein ShahsavaraniDepartment of Cell and Molecular Biology, Faculty of Life Science and Biotechnology, Shahid Beheshti University, Tehran, Iran.
Hamid AghajanDepartment of Electrical Engineering, Sharif University of Technology, Tehran, Iran.
Parvaneh MehrbodInfluenza and Respiratory Viruses Department, Pasteur Institute of Iran, Tehran, Iran.
Mostafa Salehi-VaziriCOVID-19 National Reference Laboratory, Pasteur Institute of Iran, Tehran, Iran.
Fatemeh FotouhiInfluenza and Respiratory Viruses Department, Pasteur Institute of Iran, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a label-free method for detection of the SARS-CoV-2 virus in nasopharyngeal swab samples without purification steps and multiplication of the target which simplifies and expedites the analysis process. The kit consists of a textile grid on which liquid crystals (LC) are deposited and the grid is placed in a crossed polarized microscopy. The swab samples are subsequently placed on the LCs. In the presence of a particular biomolecule, the direction of LCs changes locally based on the properties of the biomolecule and forms a particular pattern. As the swab samples are not perfectly purified, image processing and machine learning techniques are employed to detect the presence of specific molecules or quantify their concentrations in the medium. The method can differentiate negative and positive COVID-19 samples with an accuracy of 96% and also differentiate COVID-19 from influenza types A and B with an accuracy of 93%. The kit is portable, simple to manufacture, convenient to operate, cost effective, rapid and sensitive. The simplicity of the specimen processing, the speed of image acquisition, and fast diagnostic operations enable the deployment of the proposed technique for performing extensive on-spot screening of COVID-19 in public places.

Indexed as

COVID-19DiagnosticInfluenza types A and BLiquid crystalsMachine learning

Identifiers

PMID36097520
PMCPMC9452410

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.